An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia

被引：2
|
作者：
Brandwein, Joseph M. [1 ]
Hallett, Darren [1 ]
Karkhaneh, Mohammad [2 ]
Zhu, Nancy [1 ]
Liew, Elena [1 ]
Bolster, Lauren [1 ]
Hamilton, Marlene [1 ]
Patterson, Jeffrey [1 ]
Taparia, Minakshi [1 ]
Wu, Cynthia [1 ]
Van Slyke, Tiffany [1 ]
Bankar, Aniket [1 ]
Saini, Lalit [3 ]
机构：
[1] Univ Alberta, Dept Med, Edmonton, AB, Canada
[2] Inst Hlth Econ, Edmonton, AB, Canada
[3] London Hlth Sci Ctr, Dept Med, London, ON, Canada
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 01期
关键词：
OUTCOMES;
D O I：
10.1002/ajh.26012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E17 / E20
页数：5
相关论文
共 50 条
  • [1] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Reville, Patrick K.
    Kadia, Tapan
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [2] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Patrick K. Reville
    Tapan Kadia
    Current Treatment Options in Oncology, 2020, 21
  • [3] Leukapheresis in patients newly diagnosed with acute myeloid leukemia
    Villgran, Vipin
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Lim, Seah H.
    Redner, Robert L.
    Im, Annie
    Sehgal, Alison
    Dorritie, Kathleen A.
    Kiss, Joseph E.
    Normolle, Daniel
    Boyiadzis, Michael
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 55 (02) : 216 - 220
  • [4] An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
    Swan Lin
    Naveed Shaik
    Geoffrey Chan
    Jorge E. Cortes
    Ana Ruiz-Garcia
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 451 - 459
  • [5] An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
    Lin, Swan
    Shaik, Naveed
    Chan, Geoffrey
    Cortes, Jorge E.
    Ruiz-Garcia, Ana
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 451 - 459
  • [6] Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
    Gibson, Amber
    Dickson, Samantha
    McCall, David
    Garcia, Miriam
    Connors, Jeremy
    He, Jiasen
    Roth, Michael
    Nunez, Cesar
    Cuglievan, Branko
    PEDIATRIC BLOOD & CANCER, 2024,
  • [7] Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia
    Ritchie, Ellen K.
    Feldman, Eric J.
    Christos, Paul J.
    Rohan, Sarah D.
    Lagassa, Catherine B.
    Ippoliti, Cindy
    Scandura, Joseph M.
    Carlson, Karen
    Roboz, Gail J.
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2003 - 2007
  • [8] Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Alary, Anne-Sophie
    Saillard, Colombe
    Hicheri, Yosr
    Mohty, Bilal
    Rey, Jerome
    D'Incan, Evelyne
    Charbonnier, Aude
    Villetard, Ferdinand
    Maisano, Valerio
    Lombardi, Laura
    Ittel, Antoine
    Mozziconacci, Marie-Joelle
    Gelsi-Boyer, Veronique
    Vey, Norbert
    CANCERS, 2022, 14 (08)
  • [9] Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
    Jonas, Brian A.
    Wei, Andrew H.
    Recher, Christian
    DiNardo, Courtney D.
    Jang, Jun-Ho
    Pratz, Keith
    Panayiotidis, Panayiotis
    Montesinos, Pau
    Yeh, Su-Peng
    Ivanov, Vladimir
    Fiedler, Walter
    Yamauchi, Takahiro
    Duan, Yinghui
    Mendes, Wellington
    Potluri, Jalaja
    Tews, Bjorn
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E299 - E303
  • [10] Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities
    Oshikawa, Gaku
    Sasaki, Koji
    CANCERS, 2023, 15 (08)
12345